News Medical

Single antiplatelet therapy after TAVR linked to lower mortality and bleeding

Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after transcatheter aortic valve ...
Hosted on MSN

DAPT After TAVR: Harm Bleeds Into Mortality Territory

WASHINGTON -- Beyond bleeding alone, a regimen of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) was associated with excess mortality, based on observational data ...
Medscape

PARTNER A: Even Mild Paravalvular Leaks Linked With Higher Mortality at Two Years

March 26, 2012 (Chicago, Illinois) — Paravalvular leaks--a phenomenon virtually unheard of in the surgical valve replacement era--have truly been propelled into the limelight today, with the ...
News Medical

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...
EurekAlert!

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half

Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after ...
Medical Device and Diagnostic Industry (MD+DI)

TAVR Medicare Coverage Debate Gets Messy

Edwards pushes CMS to expand Medicare TAVR coverage to asymptomatic patients, sparking controversy among physicians over ...
Medscape

SURTAVI: TAVR, Surgical Aortic-Valve Replacement Stand Toe-to-Toe in Intermediate-Risk Patients

WASHINGTON, DC — (Updated with commentary) The SURTAVI trial hit its noninferiority end point, making it the second prospective randomized trial to show transcatheter aortic-valve replacement (TAVR) ...
Kaleido Scope

Still and Cardiothoracic Surgery faculty publish findings on outcomes for high-risk patients following TAVR explantations

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
EurekAlert!

Younger patients with asymptomatic aortic stenosis who undergo transcatheter aortic valve replacement experience lower rates of serious cardiovascular events, including stroke

Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with ...
MD&M East

Medtronic Breaks Out Strong TAVR Data at ACC

Medtronic reported late-breaking data on five-year outcomes from the Evolut Low Risk Trial. The Dublin-based company said data shows, vs. surgery, the Evolut transcatheter aortic valve replacement ...
TCTMD

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

One-year mortality rates—both cardiac and noncardiac—have been nudging upwards in recent years, according to an analysis of US data from 2017 to 2022. The COVID-19 pandemic could have driven the shift ...